Literature DB >> 18621847

A prospective longitudinal study comparing a radical retropubic prostatectomy and permanent prostate brachytherapy regarding the health-related quality of life for localized prostate cancer.

Katsuyoshi Hashine1, Yoshito Kusuhara, Noriyoshi Miura, Akitomi Shirato, Yoshiteru Sumiyoshi, Masaaki Kataoka.   

Abstract

OBJECTIVE: The health-related quality of life (HRQOL) after a radical retropubic prostatectomy (RRP) or a permanent prostate brachytherapy (PPB) was prospectively compared at a single institute.
METHODS: Between 2003 and 2005, 122 patients were treated by RRP and 82 patients were treated by PPB. A QOL survey was completed at baseline, and 1, 3, 6 and 12 months after treatment, prospectively.
RESULTS: The general HRQOL was not different between the RRP and PPB groups after 3 months. However, at 1 month after treatment, the general HRQOL scores, except for general health, were significantly better in the PPB group than that in the RRP group. Moreover, the disease-specific QOL was worse in urinary and sexual functions in the RRP group. Urinary function in the RRP group had not recovered to baseline after 12 months. Although the urinary function in the PPB group was better than that of the RRP group, urinary bother continued to worsen until 6 months and thereafter it recovered gradually. The bowel function was not worse in the PPB group but bowel bother was worse at 6 months in the PPB group. In the RRP group, the patients with nerve sparing demonstrated better in sexual function than those without nerve sparing, but the recovery did not reach the level of the PPB group.
CONCLUSIONS: This prospective study revealed the differences in the QOL after RRP and PPB. These results will be helpful for making treatment decisions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18621847     DOI: 10.1093/jjco/hyn059

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  5 in total

1.  Health-related quality of life using SF-8 and EPIC questionnaires after treatment with radical retropubic prostatectomy and permanent prostate brachytherapy.

Authors:  Katsuyoshi Hashine; Yoshito Kusuhara; Noriyoshi Miura; Akitomi Shirato; Yoshiteru Sumiyoshi; Masaaki Kataoka
Journal:  Jpn J Clin Oncol       Date:  2009-05-28       Impact factor: 3.019

2.  Health-related quality of life following radical prostatectomy: long-term outcomes.

Authors:  Andrew G Matthew; Shabbir M H Alibhai; Tal Davidson; Kristen L Currie; Haiyan Jiang; Murray Krahn; Neil E Fleshner; Robin Kalnin; Alyssa S Louis; B Joyce Davison; John Trachtenberg
Journal:  Qual Life Res       Date:  2014-03-09       Impact factor: 4.147

3.  The ProCaSP study: quality of life outcomes of prostate cancer patients after radiotherapy or radical prostatectomy in a cohort study.

Authors:  Nora Eisemann; Sandra Nolte; Maike Schnoor; Alexander Katalinic; Volker Rohde; Annika Waldmann
Journal:  BMC Urol       Date:  2015-04-10       Impact factor: 2.264

4.  Independent predictors of biochemical recurrence after radical prostatectomy: a single center experience.

Authors:  Marius Kinčius; Aivaras Jonas Matjošaitis; Darius Trumbeckas; Ramūnas Mickevičius; Daimantas Milonas; Mindaugas Jievaltas
Journal:  Cent European J Urol       Date:  2011-03-18

5.  Failure to address potential bias in non-randomised controlled clinical trials may cause lack of evidence on patient-reported outcomes: a method study.

Authors:  Frank Peinemann; Alexander Michael Labeit; Christian Thielscher; Michael Pinkawa
Journal:  BMJ Open       Date:  2014-06-04       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.